SRD5A1 Genotype Frequency Differences in Women with Mild versus Severe Premenstrual Symptoms

REFERENCES

• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders ( 4th ed., text rev.). Arlington, VA: Author.
   Google Scholar
• Andréen, L., Sundström-Poromaa, I., Bixo, M., Andersson, A., Nyberg, S., & Bäckström, T. (2005). Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology, 30, 212–224.
   PubMed Web of Science ®Google Scholar
• Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., & Lambert, J. J. (2006). Neuroactive steroids and inhibitory neurotransmission: Mechanisms of action and physiological relevance. Neuroscience, 138, 821–829.
   PubMedGoogle Scholar
• Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991). Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Research, 561(1), 157–161.
   PubMedGoogle Scholar
• Bitran, D., Klibansky, D. A., & Martin, G. A. (2000). The neurosteroid pregnanolone prevents anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology (Berl), 15(1), 31–37.
   Google Scholar
• Borenstein, J. E., Dean, B. B., Leifke, E., Korner, P., & Yonkers, K. A. (2007). Differences in symptom scores and health outcomes in premenstrual syndrome. Journal of Women's Health, 16(8), 1139– 1144.
   PubMed Web of Science ®Google Scholar
• Carl, P., Høgskilde, S., Nielsen, J. W., Sorensen, M. B., Lindholm, M., Karlen, B., & Bäckstrøm, T. (1990). Pregnanolone emulsion: A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia, 45(3), 189–197.
   PubMedGoogle Scholar
• Condon, J. T. (1993). The premenstrual syndrome: A twin study. British Journal of Psychiatry, 162, 481–486.
   PubMed Web of Science ®Google Scholar
• Consensus Panel on Genetic/Genomic Nursing Competencies. (2009). Essentials of genetic and genomic nursing: Competencies, curricula guidelines, and outcome indicators (2nd ed.). Silver Spring, MD: American Nurses Association.
   Google Scholar
• Dhingra, V., Magnay, J. L., O'Brien, P. M. S., Chapman, G., Fryer, A. A., & Ismail, K. M. K. (2007). Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstetrics and Gynecology, 110(4), 788–792.
   PubMedGoogle Scholar
• Dick, D. M., Plunkett, J., Wetherill, L. F., Xuei, X., Goate, A., Hesselbrock, V., … Foroud, T. (2006). Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample. Alcoholism: Clinical and Experimental Research, 30(7), 1101–1110.
   PubMed Web of Science ®Google Scholar
• Elder, B. L. & Mosack, V. (2011). Genetics of depression: An overview of the current science. Issues in Mental Health Nursing, 32, 192–202.
   PubMedGoogle Scholar
• Freeman, E. W. (2007). The clinical presentation and course of premenstrual symptoms. In P. M. S. O'Brien, A. Rapkin, & P. J. Schmidt (Eds.), The premenstrual syndromes: PMS and PMDD (pp. 55–61). London, UK: Informa.
   Google Scholar
• Friedman, L., Gibbs, T. T., & Farb, D. H. (1993). γ-Aminobutyric acidA receptor regulation: Chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Molecular Pharmacology, 44, 191–197.
   PubMed Web of Science ®Google Scholar
• Gulinello, M., Gong, Q. H., Li, X., & Smith, S. S. (2001). Short-term exposure to a neuroactive steroid increases alpha4 GABAA receptor subunit levels in association with increased anxiety in the female rat. Brain Research, 910, 55–66.
   PubMed Web of Science ®Google Scholar
• Halbreich, U. (2003). The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology, 28, 55–99.
   Web of Science ®Google Scholar
• Halbreich, U., O'Brien, P. M. S., Eriksson, E., Backstrom, T., Yonkers, K. A., & Freeman, E. W. (2006). Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs, 20(7), 523–547.
   PubMed Web of Science ®Google Scholar
• Huo, L., Straub, R. E., Roca, C., Schmidt, P. J., Shi, K., Vakkalanka, R., … Rubinow, D. R. (2007). Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biological Psychiatry, 62, 925–933.
   PubMed Web of Science ®Google Scholar
• Kendler, K. S., Karkowski, L. M., Corey, L. A., & Neale, M. C. (1998). Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. American Journal of Psychiatry, 155(9), 1234–1240.
   PubMedGoogle Scholar
• Kendler, K. S., Silberg, J. L., Neale, M. C., Kessler, R. C., Heath, A. C., & Eaves, L. J. (1992). Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study. Psychological Medicine, 22, 85–100.
   PubMedGoogle Scholar
• Kim, S. A., Kim, J. H., Park, M., Cho, I. H., & Yoo, H. J. (2006). Association of GABRB3 polymorphisms with autism spectrum disorder in Korean trios. Neuropsychobiology, 54, 160–165.
   PubMedGoogle Scholar
• Landgren, S., Aasly, J., Bäckström, T., Dubrovsky, B., & Danielsson, E. (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiologica Scandinavica, 131(1), 33–42.
   PubMedGoogle Scholar
• Lewis, R. (2010). Human genetics: Concepts and applications (9th ed.). New York, NY: McGraw-Hill.
   Google Scholar
• Lo, W-S., Harano, M., Gawlik, M., Yu, Z., Chen, J., Pun, F. W., … Xue, H. (2007). GABRB2 association with schizophrenia: Commonalities and differences between ethnic groups and clinical subtypes. Biological Psychiatry, 61, 653–660.
   PubMedGoogle Scholar
• Lou, X-Y., Ma, J. Z., Sun, D., Payne, T. J., & Li, M. D. (2007). Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Human Molecular Genetics, 16(2), 142–153.
   PubMedGoogle Scholar
• Miczek, K. A., Fish, E. W., & De Bold, J. F. (2003). Neurosteroids, GABAA receptors, and escalated aggressive behavior. Hormones and Behavior, 44, 242–257.
   PubMed Web of Science ®Google Scholar
• Miller, A., Vo, H., Huo, L., Roca, C., Schmidt, P. J., & Rubinow, D. R. (2010). Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls. Journal of Psychiatric Research, 44, 788–794.
   PubMedGoogle Scholar
• N-Wihlbäck, A-C., Sundström-Poromaa, I., & Bäckström, T. (2006). Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology (Berl), 186(3), 388–401.
   PubMedGoogle Scholar
• Olson, R. W. & Tobin, A. J. (1990). Molecular biology of the GABAA receptors. The FASEB Journal, 4(5), 1469–1480.
   PubMedGoogle Scholar
• Praschak-Rieder, N., Willeit, M., Winkler, D., Neumeister, A., Hilger, E., Zill, P., … Kasper, S. (2002). Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder. European Neuropsychopharmacology, 12, 129–134.
   PubMed Web of Science ®Google Scholar
• Rabow, L. E., Russek, S. J., & Farb, D. H. (1995). From ion currents to genomic analysis: Recent advances in GABAA receptor research. Synapse, 21(3), 189–274.
   PubMedGoogle Scholar
• Rapkin, A. J., & Kuo, J. (2007). Neurotransmitter physiology: The basics for understanding premenstrual syndrome. In P. M. S. O'Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The premenstrual syndromes: PMS and PMDD (pp. 69–81). London, UK: Informa.
   Google Scholar
• Rapley R., & Harbron S. (Eds.). (2004). Molecular analysis and genome discovery. Chichester, UK. John Wiley & Sons.
   Google Scholar
• Rupprecht, R. (2003). Neuroactive steroids: Mechanism of action and neuropsychopharmacological properties. Psychoneuroendocrinology, 28, 139–168.
   PubMed Web of Science ®Google Scholar
• Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams L. F., & Rubinow, D. R. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England Journal of Medicine, 338(4), 209–216.
   PubMed Web of Science ®Google Scholar
• Schmidt, P. J., & Rubinow, D. R. (2007). Future directions in the pathophysiology of premenstrual dysphoric disorder: Steps to future treatments. In P. M. S. O'Brien, A. Rapkin, & P. J. Schmidt (Eds.), The premenstrual syndromes: PMS and PMDD (pp. 171–179). London, UK: Informa.
   Google Scholar
• Slade, P., Haywood, A., & King, H. (2009). A qualitative investigation of women's experiences of the self and others in relation to their menstrual cycle. British Journal of Health Psychology, 14, 127–141.
   PubMed Web of Science ®Google Scholar
• Soyka, M., Preuss, U. W., Hesselbrock, V., Zill, P., Koller, G., & Bondy, B. (2008). GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence. Journal of Psychiatric Research, 42(3), 184–191.
   PubMed Web of Science ®Google Scholar
• Steiner, M., Macdougall, M., & Brown, E. (2003). The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women's Mental Health, 6, 203–209.
   PubMedGoogle Scholar
• Syvänen, A.-C. (2001). Accessing genetic variation: Genotyping single nucleotide polymorphisms. Nature Reviews Genetics, 2(12), 930–942.
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services. (2008). Mental Health Medications. NIH Publication No. 08–3929. Washington, DC: National Institutes for Mental Health.
   Google Scholar
• Wilson, C. A., Turner, C. W., & Keye, W. R. (1991). Firstborn adolescent daughters and mothers with and without premenstrual syndrome: A comparison. Journal of Adolescent Health, 12(2), 130–137.
   PubMedGoogle Scholar
• Yang, M., Wallenstein, G., Hagan, M., Guo, A., Chang, J., & Kornstein, S. (2008). Burden of premenstrual dysphoric disorder on health-related quality of life. Journal of Women's Health, 17(1), 113–121.
   PubMed Web of Science ®Google Scholar
• Yonkers, K. A., & McCunn, K. L. (2007). Comorbidity of premenstrual syndrome and premenstrual dysphoric disorder with other psychiatric conditions. In P. M. S. O'Brien, A. J. Rapkin, & P. J. Schmidt (Eds.), The premenstrual syndromes: PMS and PMDD (pp. 49–54). London, UK: Informa.
   Google Scholar
• Yonkers, K. A., O'Brien, P. M. S., & Eriksson, E. (2008). Premenstrual syndrome. Lancet, 371, 1200–1210.
   PubMed Web of Science ®Google Scholar
• Yu, R., Follesa, P., & Ticku, M. K. (1996). Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Molecular Brain Research, 41, 163–168.
   PubMedGoogle Scholar